Overall, our data indicate that phenotypic heterogeneity will ultimately be observed in human TARS1-related recessive disease, and that individuals with bi-allelic TARS1 variants should be carefully evaluated for lung disease. This evidence concerns the gene TARS1 and lung disorder.